{
  "title": "Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones",
  "url": "https://openalex.org/W2155167075",
  "year": 2014,
  "authors": [
    {
      "id": "https://openalex.org/A5101669271",
      "name": "Wenya Liu",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    },
    {
      "id": "https://openalex.org/A5110167902",
      "name": "É. Delabrousse",
      "affiliations": [
        "Centre Hospitalier Universitaire de Besançon",
        "Université de franche-comté"
      ]
    },
    {
      "id": "https://openalex.org/A5058339653",
      "name": "Oleg Blagosklonov",
      "affiliations": [
        "Centre Hospitalier Universitaire de Besançon",
        "Université de franche-comté"
      ]
    },
    {
      "id": "https://openalex.org/A5077599099",
      "name": "Jing Wang",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    },
    {
      "id": "https://openalex.org/A5068259945",
      "name": "Hongchun Zeng",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    },
    {
      "id": "https://openalex.org/A5060591448",
      "name": "Yi Jiang",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    },
    {
      "id": "https://openalex.org/A5100647102",
      "name": "Jian Wang",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    },
    {
      "id": "https://openalex.org/A5087228605",
      "name": "Yongde Qin",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    },
    {
      "id": "https://openalex.org/A5016703858",
      "name": "Dominique A. Vuitton",
      "affiliations": [
        "Université de franche-comté"
      ]
    },
    {
      "id": "https://openalex.org/A5100622844",
      "name": "Hao Wen",
      "affiliations": [
        "First Affiliated Hospital of Xinjiang Medical University",
        "Xinjiang Medical University"
      ]
    }
  ],
  "references": [
    "https://openalex.org/W1985672530",
    "https://openalex.org/W2023190945",
    "https://openalex.org/W2101645713",
    "https://openalex.org/W2029787346",
    "https://openalex.org/W2063133988",
    "https://openalex.org/W2180569476",
    "https://openalex.org/W2058819379",
    "https://openalex.org/W2109500043",
    "https://openalex.org/W1963602111",
    "https://openalex.org/W2146312491",
    "https://openalex.org/W4236791790",
    "https://openalex.org/W1951263213",
    "https://openalex.org/W2005329295",
    "https://openalex.org/W2127509295",
    "https://openalex.org/W2045532313",
    "https://openalex.org/W1971360857",
    "https://openalex.org/W2001297806",
    "https://openalex.org/W2044545437",
    "https://openalex.org/W2090646490",
    "https://openalex.org/W2152320594",
    "https://openalex.org/W2054497696",
    "https://openalex.org/W1441093657",
    "https://openalex.org/W2059365912",
    "https://openalex.org/W2162001280",
    "https://openalex.org/W2005674453",
    "https://openalex.org/W2126514483",
    "https://openalex.org/W2158640207",
    "https://openalex.org/W2002544931",
    "https://openalex.org/W2074250292",
    "https://openalex.org/W1996774819",
    "https://openalex.org/W2326925542",
    "https://openalex.org/W2037622579",
    "https://openalex.org/W2167523955",
    "https://openalex.org/W2147595494",
    "https://openalex.org/W2165995873",
    "https://openalex.org/W2117006065",
    "https://openalex.org/W2063406263",
    "https://openalex.org/W2163679051",
    "https://openalex.org/W2052216964",
    "https://openalex.org/W2088114645",
    "https://openalex.org/W2017896252",
    "https://openalex.org/W2046190737",
    "https://openalex.org/W2043057790",
    "https://openalex.org/W2025439121",
    "https://openalex.org/W2057013526",
    "https://openalex.org/W2073548080",
    "https://openalex.org/W2100935340",
    "https://openalex.org/W2333599013",
    "https://openalex.org/W2501928633",
    "https://openalex.org/W3030441759",
    "https://openalex.org/W2028657274",
    "https://openalex.org/W249602592",
    "https://openalex.org/W2096773270",
    "https://openalex.org/W4255848334",
    "https://openalex.org/W2079496814",
    "https://openalex.org/W2746285725",
    "https://openalex.org/W2335125781",
    "https://openalex.org/W2364210310"
  ],
  "abstract": "Hepatic Alveolar Echinococcosis (HAE), caused by larvae of Echinococcus multilocularis, is a rare but potentially lethal parasitic disease. The first diagnostic suspicion is usually based on hepatic ultrasound exam performed because of abdominal symptoms or in the context of a general checkup; HAE diagnosis may thus also be an incidental finding on imaging. The next step should be Computed Tomography (CT) or Magnetic Resonance Imaging (MRI). They play an important role in the initial assessment of the disease; with chest and brain imaging, they are necessary to assess the PNM stage (parasite lesion, neighboring organ invasion, metastases) of a patient with AE. Performed at least yearly, they also represent key exams for long-term follow-up after therapeutic interventions. Familiarity of radiologists with HAE imaging findings, especially in the endemic regions, will enable earlier diagnosis and more effective treatment. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is currently considered to be the only noninvasive, albeit indirect, tool for the detection of metabolic activity in AE. Delayed acquisition of images (3 hrs after FDG injection) enhances its sensitivity for the assessment of lesion metabolism and its reliability for the continuation/withdrawal of anti-parasite treatment. However, sophisticated equipment and high cost widely limit PET/CT use for routine evaluation. Preliminary studies show that new techniques, such as contrast-enhanced ultrasound (US), Dual Energy CT or Spectral CT, and Diffusion-Weighted MRI, might also be useful in detecting the blood supply and metabolism of lesions. However, they cannot be recommended before further evaluation of their reliability in a larger number of patients with a variety of locations and stages of AE lesions.",
  "full_text": "Innovation in hepatic alveolar echinococcosis imaging: best use\nof old tools, and necessary evaluation of new ones\nWenya Liu1, Éric Delabrousse 2,3, Oleg Blagosklonov3,4, Jing Wang1, Hongchun Zeng 5, Yi Jiang 1,\nJian Wang1, Y ongde Qin1, Dominique Angèle Vuitton 3, and Hao Wen 6,*\n1 Imaging Center, First Afﬁliated Hospital, Xinjiang Medical University Hospital, No. 1 Liyushan road, Urumqi 830011, PR China\n2 Department of Visceral Radiology, University Hospital Jean Minjoz, 25030 Besançon, France\n3 WHO-Collaborating Centre for Prevention and Treatment of Human Echinococcosis, University of Franche-Comté\nand University Hospital, 25030 Besançon, France\n4 Department of Nuclear Medicine, University Hospital Jean Minjoz, 25030 Besançon, France\n5 Department of Ultrasonography, First Afﬁliated Hospital, Xinjiang Medical University Hospital, No. 1 Liyushan road,\nUrumqi 830011, China\n6 Department of Hepatic surgery, First Afﬁliated Hospital, Xinjiang Medical University Hospital, No. 1 Liyushan road,\nUrumqi 830011, China\nReceived 14 July 2014, Accepted 11 December 2014, Published online 23 December 2014\nAbstract – Hepatic Alveolar Echinococcosis (HAE), caused by larvae of Echinococcus multilocularis, is a rare but\npotentially lethal parasitic disease. The ﬁrst diagnostic suspicion is usually based on hepatic ultrasound exam per-\nformed because of abdominal symptoms or in the context of a general checkup; HAE diagnosis may thus also be\nan incidental ﬁnding on imaging. The next step should be Computed Tomography (CT) or Magnetic Resonance Imag-\ning (MRI). They play an important role in the initial assessment of the disease; with chest and brain imaging, they are\nnecessary to assess the PNM stage (parasite lesion, neighboring organ invasion, metastases) of a patient with AE.\nPerformed at least yearly, they also represent key exams for long-term follow-up after therapeutic interventions.\nFamiliarity of radiologists with HAE imaging ﬁndings, especially in the endemic regions, will enable earlier diagnosis\nand more effective treatment. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is currently consid-\nered to be the only noninvasive, albeit indirect, tool for the detection of metabolic activity in AE. Delayed acquisition\nof images (3 hrs after FDG injection) enhances its sensitivity for the assessment of lesion metabolism and its reliabil-\nity for the continuation/withdrawal of anti-parasite treatment. However, sophisticated equipment and high cost widely\nlimit PET/CT use for routine evaluation. Preliminary studies show that new techniques, such as contrast-enhanced\nultrasound (US), Dual Energy CT or Spectral CT, and Diffusion-Weighted MRI, might also be useful in detecting\nthe blood supply and metabolism of lesions. However, they cannot be recommended before further evaluation of their\nreliability in a larger number of patients with a variety of locations and stages of AE lesions.\nKey words: Hepatic Alveolar Echinococcosis, Computed Tomography, Magnetic Resonance Imaging,\nFluoroDeoxyGlucose-Positron Emission Tomography, Functional evaluation, Innovation techniques .\nRésumé – Innovation dans l’imagerie de l’échinococcose alvéolaire hépatique : meilleur usage des anciens\noutils et nécessaire évaluation des nouveaux.L ’échinococcose alvéolaire hépatique (EAH), causée par les larves\nd’Echinococcus multilocularis, est une maladie parasitaire rare mais potentiellement fatale. La première suspicion\ndiagnostique provient généralement d’une échographie hépatique réalisée en raison de symptômes abdominaux, ou à\nl’occasion d’un bilan plus général; la découverte de l’EAH est donc parfois fortuite. L ’étape suivante doit comporter un\nscanner et/ou une imagerie en résonance magnétique nucléaire (IRM), qui, incluant la recherche de localisations\npulmonaires et cérébrales, jouent un rôle important dans l’évaluation initiale de la maladie et sont absolument\nnécessaires pour déterminer le stade PNM (lésion parasitaire, invasion des organes proches, métastases) de l’EA.\nRépétées au moins une fois par an, elles représentent les examens-clés pour le suivi des patients à long-terme et le\nmanagement de leur traitement. Une meilleure familiarité des radiologues avec l’imagerie de l’EAH contribuerait\n*Corresponding author: dr.wenhao@163.com\nInnovation for the Management of Echinococcosis.\nInvited editors: Dominique A. Vuitton, Laurence Millon, Bruno Gottstein and Patrick Giraudoux\nParasite 2014, 21,7 4\n/C211 W . Liu et al., published by EDP Sciences, 2014\nDOI: 10.1051/parasite/2014072 Available online at:\nwww.parasite-journal.org\nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0),\nwhich permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\nOPEN ACCESSREVIEW ARTICLE\nlargement au diagnostic précoce de l’affection dans les zones d’endémie et à un traitement plus efﬁcace. La Tomographie\npar Émission de Positons au Fluorodéoxyglucose (FDG-TEP) est actuellement considérée comme la meilleure technique\nnon-invasive, bien qu’indirecte, d’évaluation métabolique de l’EAH. L ’acquisition tardive (3 heures après injection du\nFDG) des images améliore sa sensibilité diagnostique et sa ﬁabilité comme indicateur de poursuite/arrêt du traitement\nantiparasitaire. Cependant, l’équipement sophistiqué et le coût élevé de cette technique en limite considérablement\nl’utilisation en routine. Les résultats préliminaires obtenus avec des techniques plus abordables d’évaluation\nfonctionnelle comme l’échographie de contraste, le scanner en acquisition spectrale ou bi-énergie, ou l’IRM pondérée\nen diffusion, suggèrent qu’elles sont capables d’évaluer aussi la suppléance vasculaire et l’activité métabolique dans\ncette indication. Elles ne peuvent cependant pas être recommandées pour une utilisation de routine avant que des études\nsur un nombre de patients plus élevé, présentant des localisations et des stades évolutifs variés, n’aient été réalisées.\n1. Introduction\nHepatic Alveolar Echinococcosis (HAE) caused by the\nlarvae (metacestode) of Echinococcus multilocularisis a rare\ndisease only present in the northern hemisphere, compared\nwith Cystic Echinococcosis (CE) caused by Echinococcus\ngranulosus, which is present worldwide. Although\nhistopathologically a benign disease, due to a parasite, HAE\nshows the characteristics of a malignant tumor with destructive\ntissue growth, invasion of adjacent organs, and distant\ndissemination [12, 31].\nBecause HAE is a tumor-like and chronic disease, with a\nlatent stage that may last for years before signs and symptoms\ndevelop, the diagnosis primarily depends on imaging tech-\nniques including ultrasound (US), computed tomography\n(CT), and magnetic resonance imaging (MRI) [ 4, 32].\nAlthough HAE is still often diagnosed on clinical symptoms\nin low-resource countries, including China where the disease\nis endemic in rather remote areas of the western provinces\nand autonomous regions [23], it is more and more often dis-\nclosed incidentally on imaging in Europe, the second major\ne n d e m i ca r e af o rt h i sd i s e a s e[47]. Depending on the stage\nwhen they are discovered and their location, there is a spectrum\nof possible images that are often characteristic of the disease\nbut may nevertheless lead to difﬁculties in differential diagno-\nsis. Imaging techniques are also used for the follow-up of\npatients, with the aim of evaluating the efﬁcacy of the\ntreatment (surgery and chemotherapy using albendazole) and\nthe viability of the parasite. Ultrasound and the conventional\nradiological imaging techniques are not well adapted to this\npurpose, and Positron Emission Tomography (PET) with\n[18F]ﬂuorodeoxyglucose (FDG) as a radioisotope tracer has been\nproposed for such an assessment [37]. More sophisticated imag-\ning techniques, such as Contrast-Enhanced Ultrasound (CEUS),\ndual energy CT and spectral CT, or MR-Diffusion-Weighted\nImaging (DWI), have become available; some of them could be\npromising in their applications to HAE. In addition, whatever\nthe technique used to obtain images of AE lesions, their correla-\ntion with the underlying complex pathology of HAE has very\nrarely been studied. However, more precise delineation of the\npathological ‘‘substratum’’ ofthe images obtained with the vari-\nous available techniques would be important to better interpret\nimaging aspects. This review will focus on the images obtained\nfrom well-validated imaging techniques in HAE and when each\ntechnique should be used for diagnosis and follow-up. It will then\ndescribe the images obtained with newer imaging procedures\nrecently introduced and try to delineate their pathological\ncounterpart. Whenever possible, it will tentatively establish their\nadditional value, if any, for diagnosis and follow-up.\n2. Pathology of HAE\nHumans are accidentally infected withE. multilocularisby\ningestion of eggs dispersed in soil, vegetables, and animal fur,\nand by the feces of carnivores (foxes and dogs) harboring adult\ntapeworms of this species. Oncospheres hatched from eggs in\nthe small intestine of humans migrate via the portal system to\nthe liver, where they differentiate and develop into the\nmetacestode stage. The larva causes invasive and destructive\n2 W . Liu et al.: Parasite 2014, 21,7 4\n肝泡型包虫病影像学新进展：传统影像学工具及新的成像技术\n摘要\n肝泡型包虫病是一种少见的但具有致命风险的寄生虫病。其初诊往往基于患者出现腹部不适症状或常规体检时所进\n行的超声检查；也就是说肝泡型包虫病多数情况是在影像学检查时偶然发现的。接下来这些患者就要进行肝脏的\n CT\n或磁共振（MRI）扫描。这两项检查对本病的初步评估起着重要作用，头颅、胸部的扫描也必须同时进行以便进行\nPNM 分期。CT 和 MR 在治疗后的随访工作中仍起着关键作用，建议至少一年进行一次随访检查。对泡型包虫病影\n像诊断富有经验的放射科医师，尤其是那些在疾病流行区域的医师，往往能够对本病进行早期诊断并指导更有效的\n治疗。氟脱氧葡萄糖标记的正电子发射断层成像（FDG-PET）是目前所公认唯一的一种能以间接无创的方式评价泡型\n包虫代谢活性的检测工具。FDG-PET 延迟显像（在注射 FDG3\n 小时后）对判断包虫病灶代谢活性敏感并且能够为决定\n是否停用化疗药物提供有力的依据。然而 PET/CT 这种高端设备以其高昂的检查费用使它不能够普及应用来进行泡\n型包虫病的评估。初步研究表明，新的成像技术如超声造影、双能/能谱 CT 和磁共振弥散加权成像，有望能够检测\n病变的血供情况及判断代谢活性。然而，这些成像方法目前还不能推广，尚需进行多中心大样本和不同分期病例的\n进一步观察来确定其临床应用的可靠性。\nchanges in the liver and behaves like a malignant neoplasm.\nSince clinical symptoms usually do not become evident\nuntil 10 or more years after initial parasite infection, early\ndiagnosis and treatment especially during the asymptomatic\nperiod are important for the reduction of morbidity and\nmortality [8].\nThe metacestodes propagate asexually like a tumor, by\nbuds then vesicles, leading eventually to bile duct and hepatic\nvessel obstruction and organ dysfunction. Cellular immune\nsuppression of the host leads to faster growth both in experi-\nmental animals and in humans [ 2]. At gross pathologic\nanalysis, the HAE lesion appears as a whitish inﬁltrative mul-\ntivesicular mass composed of many cysts irregular in shape\nand size (diameters from <1 to 20 mm) with associated ﬁbrosis\nand calciﬁcation. There is no clear margin between the para-\nsitic tissue and the adjacent normal liver parenchyma. In the\nhuman host, both metacestode proliferation and cellular host\nresponse may produce lesions up to 15–20 cm in diameter.\nE. multilocularis actually produces multiple vesicles (small\ncysts of 1–20 mm in diameter) that resemble alveoli, hence\nthe name of the disease, and give a ‘‘multilocular’’ aspect to\nthe lesions, hence the name of the cestode. The metacestode\ngrows by exogenous proliferation, with the vesicles progres-\nsively invading the host tissue by peripheral extension of the\nprocess originating in the ‘‘germinal layer’’, each vesicle being\nrapidly surrounded by a polysaccharide-rich ‘‘laminated layer’’\n[19]. From the very beginning of larval proliferation too, the\nimmune response of the host is characterized by the homing\nto the liver of cells such as macrophages, lymphocytes, ﬁbro-\nblasts, and myoﬁbroblasts, at the contact of the laminated layer,\nand which display a ‘‘granulomatous’ ’structure [20]. Cytokines\nand chemokines are major actors in cell homing, as well as in\ncell functions of the periparasitic inﬁltrate [ 48]. Fibrosis and\nnecrosis, which tend to limit the extension of the metacestode,\nare the main functional consequences of periparasitic cell acti-\nvation. The periparasitic cell inﬁltrate is usually located at the\nperiphery of the lesions, in areas with active proliferation of the\nmetacestode [6]. Neo-vessels accompany immune cell homing\nand are present in this ‘ ‘granulomatous’’ part of the lesion [21,\n45, 46]. Necrotic areas, conversely, are usually located in the\nmost inactive part of the lesion, where dead vesicles and ‘‘giant\ncells’’, i.e. multinuclear scavenger macrophages, are present.\nThose necrotic cavities developed in the degenerating areas\nof the metacestode, which may reach sizes up to tens of centi-\nmeters, are in no way an equivalent of CE ‘‘cysts’’. This is why\nthe term ‘‘pseudo-cyst’ ’ and not ‘ ‘cyst’’ will always be used in\nthis review to designate these necrotic areas. The word ‘‘vesi-\ncles’’ or ‘‘cysts’’ will be restricted to the elementary structure\ndeﬁned by the germinal and laminated layers of the metaces-\ntode (i.e. the active, proliferating, parasite unit). As the lesion\nheals, it invariably becomes calciﬁed; from punctuate to multi-\nple scattered and peripheral calciﬁcations, and/or sometimes a\nlarge homogeneously calciﬁed mass [39]. Progressive obstruc-\ntion of portal veins or their branches as well as a direct prolif-\nerative inﬂuence of the metacestode on normal hepatocytes are\nresponsible for liver regeneration in those segments/lobes of\nthe liver not involved in parasitic growth [28, 53].\n3. Imaging ﬁndings in HAE using well-validated\ntechniques\nImaging is the major method used for the diagnosis of\nHAE, while serological tests are used to conﬁrm diagnostic\nsuspicion raised by imaging observations [ 16]. In general,\nUS is the initial investigative modality of choice for the detec-\ntion of HAE, including for mass screening [ 3, 11, 29]a n di s\nusually complemented by CT scans which best show the calci-\nﬁcations that are characteristic of HAE. CT is also able to com-\nprehensively depict the morphological changes in the liver of\nHAE patients. Though CT is the second preferred imaging\nexam, MRI is also used in combination with US when HAE\ninvolves the biliary tree, and/or to disclose the multivesicular\npathognomonic structure of the lesion, and thus ascertain AE\ndiagnosis.\n3.1. Ultrasonography (US): the imaging tool\nof choice for the detection of AE lesions\nT ypical ﬁndings in abdominal US include a hepatic mass\nwith mixed hyper- and hypoechogenicity, irregular margins,\nscattered foci of calciﬁcation, and a pseudo-cyst which is\ncaused by the central necrosis surrounded by an irregular\nring-like hyperechogenicity region which represents ﬁbrous tis-\nsue (Fig. 1). Less typical appearances include multiple clus-\ntered hemangioma-like hyperechoic nodules (referred to as\nFigure 1. Alveolar echinococcosis in a 30-year-old woman.(a) Abdominal gray-scale US image shows an irregular type heterogeneous mass\nlesion with no clear boundary in the right lobe of the liver, containing anechoic pseudo-cystic lesion and hyperechoic foci of calciﬁcation.\n(b) Color Doppler US image shows no obvious blood ﬂow signal while cystic duct is constricted.\nW . Liu et al.: Parasite 2014, 21,7 4 3\n‘‘hailstorm pattern’ ’), small calciﬁed lesions, and apparently\nisolated pseudo-cysts with massive necrosis. In the presence\nof the latter, the differential diagnosis includes benign liver\ncyst, cystadenoma, cystadenocarcinoma, and E. granulosus\nlesions. However, irregular borders and a lack of enhancement\nare suggestive features of HAE; the other lesions usually exhi-\nbit peripheral enhancement and are rarely calciﬁed. A pseudo-\ncystic appearance may also be seen in recurrent foci of HAE\nafter percutaneous drainage of primary lesions.\nColor and pulsed Doppler US images can show distortion\nand displacement of the hepatic veins, portal vein, and biliary\ntree resulting from a mass effect, invasion of the inferior vena\ncava or hepatic or portal vein walls, and secondary biliary duct\ninvolvement and intrahepatic bile duct dilation [3, 7, 8].\nUS imaging is the ﬁrst choice for screening and follow-up\ndue to its widespread availability, radiation-free method, and\nlow costs. Because of its limited contribution to the identiﬁca-\ntion of small peripheral lesions, unsatisfactory evaluation of the\nextension into the perihepatic adipose tissue and neighboring\norgans, and occasionally insufﬁcient detection of small-sized\n(<2 cm) lesions containing calciﬁcations, other imaging tech-\nniques, whenever available, should be performed for better\nevaluation.\n3.2. Computed Tomography (CT): for better\ncharacterization of AE lesions and\ntheir typical calciﬁcations\nUnenhanced CT images show an inﬁltrating tumor-\nlike hepatic mass with irregular margins and heterogeneous\ncontents with varied attenuation, including scattered\nhyper-attenuating calciﬁcations and hypo-attenuating areas\ncorresponding to necrosis ( Fig. 2a). No substantial enhance-\nment is observed within the hepatic lesion after administration\nof an intravenous contrast medium ( Fig. 2b ); however, the\nﬁbro-inﬂammatory component surrounding the parasitic tissue\nmay be enhanced faintly in the delayed phase after injection\n(Fig. 2c). In pseudo-cystic hepatic lesions, CT shows a large\nnecrotic central area surrounded by an irregular ring-like\nregion of ﬁbrous tissue that is often partly calciﬁed. If the par-\nasitic process has inﬁltrated the hilum, the intrahepatic bile\nducts typically appear dilated. Hepatomegaly of the contralat-\neral ‘ ‘healthy’’ liver lobe is often conspicuous.\nCT features of HAE lesions have been reported to be\na differential diagnosis for primary hepatic neoplasms such\nas cholangiocarcinoma, biliary cystadenoma, and biliary cyst-\nadenocarcinoma, as well as for hepatic metastases. However,\nthe CT ﬁndings of hypo-attenuation, calciﬁcation, and absence\nof contrast enhancement in a hepatic lesion usually help\nidentify it as HAE [22, 25]. Recent observations of liver metas-\ntasis-like images in patients with digestive cancer, eventually\nleading to the discovery of HAE after months of misdiagnosis,\nhave however dampened the notion of a usually easy differen-\ntial diagnosis [10]; so have hemangioma-like and liver abscess-\nlike images in patients with acquired immune suppression due\nto chemotherapy and/or anti-TNF biotherapeutic agents\n(Fig. 3)[ 50]. Such images, rarely described in the past, could\nbe due to the early disclosure of the lesions and/or to the rapid\ngrowth of the metacestode.\nThough radiation is the main drawback of CT scan, CT\nremains the mainstream modality for morphologic imaging\nassessment of HAE lesions in the majority of low-resource\ncountries or districts because CT has a clear superiority over\nMR in demonstrating calciﬁcations, especially in small clusters.\nBetter than US, it helps to determine the number, size, and loca-\ntion of lesions in the liver and allows a comprehensive preoper-\native evaluation of vascular, biliary, and extrahepatic extension,\nwhich is an important consideration when assigning a stage to\nthe patient in the PNM (parasite lesion, neighboring organ inva-\nsion, metastases) classiﬁcation (see below andTable 1)a n di n\nassessing the possibility of resection of the HAE.\n3.3. Magnetic Resonance Imaging: to disclose\npathognomonic images and perform\na pre-therapeutic assessment\nWith high resolution for soft tissue and without any radia-\ntion, MR imaging is the best modality for characterizing the\ncomponents of parasitic lesions and depicting vascular or bili-\nary tree involvement and extrahepatic extension [4, 25].\nCharacteristic MR imaging features of HAE at the middle/\nlate stage include a heterogeneous inﬁltrative mass with\nFigure 2. Alveolar echinococcosis in a 28-year-old woman.(a) Axial unenhanced CT image shows an inﬁltrative tumor-like hepatic mass\ninvolving both lobes of the liver with irregular margin and heterogeneous contents including hyper-attenuating foci of calciﬁcation scattered\nperipherally and an area of hypo-attenuation corresponding to necrosis and parasitic tissue centrally. (b) Post-contrast arterial phase shows a\nnon-enhancing, hypo-attenuating lesion. (c) Post-contrast portal-venous phase shows a faint enhancement of ﬁbro-inﬂammatory components\nsurrounding the parasitic pseudo-cyst.\n4 W . Liu et al.: Parasite 2014, 21,7 4\nirregular margins and a necrotic center that exhibits low to\nintermediate signal intensity on T1-weighted images and heter-\nogeneous signal intensity (areas of low and high signal inten-\nsity) on T2-weighted images ( Figs. 4a and 4b). Areas of\nhigh T2 signal intensity correspond to small cystic or necrotic\ncomponents, whereas areas of low T2 signal intensity corre-\nspond to ﬁbrotic or collagenous components. T2-weighted\nimages are useful for detecting small hepatic and extrahepatic\nvesicles and their typical arrangement. The multivesicular\nstructure of AE lesions, with nearly pathognomonic features\nof ‘‘honeycomb’’ or ‘‘bunch of grapes’’, is best disclosed on\nMRI T2-weighted images which thus represent the best conﬁr-\nmation imaging exam in case of difﬁcult diagnosis. Kodama\net al. [25 ], from a series of AE patients living in Hokkaido,\nJapan, proposed in 2003 a classiﬁcation of MR images in\nHAE, with ﬁve classes as follows: type 1: multiple small\nround cysts without a solid component; type 2: multiple small\nround cysts with a solid component; type 3: a solid component\nsurrounding a large and/or irregular pseudo-cyst with multiple\nsmall round cysts; type 4: a solid component without cysts;\ntype 5: a large cyst without a solid component. On a series\nof French AE patients, we studied the FDG-PET/CT character-\nization of the lesions deﬁned according to this MRI classiﬁca-\ntion and could show that the presence of vesicles/small cysts\nwas signiﬁcantly associated with positive images on\nFDG-PET/CT [ 1]. This observation strongly suggests that\ndisclosure of micro-cystic images on MRI could be a good sur-\nrogate marker of parasite viability; however, such ﬁndings\nshould be conﬁrmed by prospective studies in a higher number\nof HAE cases [1].\nMR cholangiopancreatography (MRCP) yields information\nabout the relationship between HAE lesions and the biliary\ntree; in particular, it can depict biliary dilation, a reduced num-\nber of bile ducts within the lesion, invasion of the biliary wall,\ndistortion and compression of the biliary tree, and communica-\ntion of intrahepatic bile ducts with necrotic pseudo-cystic\nregions (Fig. 4f ). Such pieces of information are precious\nbefore any decision on radical surgical resection, and before\npercutaneous or perendoscopic interventional palliative\nprocedures [4].\n3.4. Positron Emission Tomography (PET):\nan imaging tool for patient follow-up\nInformation on parasite metabolic activity cannot be\nobtained by conventional imaging techniques. In addition,\nchanges in the size of the lesions after albendazole treatment\nare slow and US as well as CT and MRI may, at best, evaluate\nabsence of progression rather than regression of lesions in most\ncases of HAE; decrease in the size of pseudo-cysts after drain-\nage is in no way evidence of lesion regression, but may be of\nhelp to reassess the technical possibility of lesion resection by\nsurgery [ 4]. [18F]FDG-PET has been proposed as a non-\ninvasive tool for the three-dimensional detection of metabolic\nactivity in HAE lesions [ 13, 37]. Location of FDG uptake\nwithin HAE lesions, at the periphery of the lesions [40], as well\nas in vitro experiments which have shown high uptake of this\nradioisotope tracer by immune cells and rather low uptake by\nE. multilocularis cells/vesicles [ 33], strongly suggest that\nFDG-PET does not evaluate parasite viability/lesion progres-\nsion directly ( Fig. 5). Increased glucose metabolism in cells\nof the host’ s response is very likely responsible for PET -\npositive images in HAE, which thus only indirectly assess dis-\nease progression [36]. As it explores only a part of the lesions\nand the images are not speciﬁc to AE, PET/CT cannot be used\nas a diagnostic tool in HAE. Nevertheless, as there is currently\nno imaging tool better adapted to the follow-up of patients with\nHAE, whenever possible, initial assessment of the metabolic\nactivity of the lesions by FDG-PET/CT before the initiation\nof any treatment may be recommended, as a basis for further\nfollow-up. However, at Besançon University Hospital, we have\ndemonstrated that delayed acquisition of the images, i.e. mea-\nsuring FDG uptake 3 hrs after injection and not only 1 hr after\ninjection as usually performed in oncology, was necessary to\nimprove the sensitivity of the procedure, and reduce the risk\nof false-negative images [9]. With this precaution, in patients\nwith radical operations, PET/CT may help detect early hepatic\nrelapses and allow timely intervention. In patients treated with\nalbendazole alone or combined with interventions aimed at\nalleviating complications, retrospective studies have shown\nthat, albeit more expensive than conventional imaging tech-\nniques, FDG-PET might prove cost-effective by permitting\nthe duration of chemotherapy to be shortened [35]. Recurrence\nof the disease after albendazole withdrawal has however been\nTable 1.PNM classiﬁcation of alveolar echinococcosis (according\nto WHO-IWGE, 2006).\nPNM Location and extension of the lesion\nP Hepatic localization of the parasite\nP X Primary parasite cannot be assessed\nP 0 No detectable parasite in the liver\nP 1 Peripheral lesions without proximal vascular and/or biliary\ninvolvement\nP 2 Central lesions with proximal vascular and/or biliary\ninvolvement of one lobe a\nP 3 Central lesions with hilar, vascular, or biliary involvement\nof both lobes and/or with involvement of two hepatic veins\nP 4 Any liver lesion with extension along the vessels b and the\nbiliary tree\nN Extrahepatic involvement of neighboring organs\n[diaphragm, lungs, pleura, pericardium, heart, gastric and\nduodenal wall, adrenal glands, peritoneum,\nretroperitoneum, parietal wall (muscles, skin, bone),\npancreas, regional lymph nodes, liver ligaments, kidneys]\nN X Not evaluable\nN 0 No regional involvement\nN 1 Regional involvement of contiguous organs or tissues\nM The absence or presence of distant Metastasis [lungs,\ndistant lymph nodes, spleen, CNS, orbital, bones, skin,\nmuscle, kidneys, distant peritoneum, and retroperitoneum]\nM X Not completely evaluated\nM 0 No metastasis\nc\nM 1 Metastasis\naFor classiﬁcation, the plane projecting between the bed of the gall\nbladder and the inferior vena cava divides the liver into two lobes.\nbVessels mean inferior vena cava, portal vein, and arteries.\ncChest X-ray and cerebral CT negative.\nW . Liu et al.: Parasite 2014, 21,7 4 5\nobserved in patients with negative PET/CT using standard\nacquisition of images [ 35]; this further supports the interest\nof late acquisition of images in HAE [ 36]. Prospective evalu-\nation is currently ongoing to delineate usefulness and best\nmodalities of PET/CT follow-up to monitor disease activity,\nto optimize therapeutic management, and, as a ﬁnal goal, to\nreassess long-term treatment with benzimidazoles on the basis\nof clearly discriminating imaging ﬁndings [44]. This is among\nthe objectives of the EchinoVista project in France [5]. Finally,\nthe use of FDG-PET/CT to disclose and monitor extrahepatic\nlocations of AE remains questionable: increased FDG uptake\nby lung, heart, and brain metastases has been observed in\nChinese patients with advanced lesions (Fig. 6); such an uptake\nis observed far more rarely in French patients with smaller\nand/or less advanced lesions (O Blagosklonov , personal obser-\nvations); this actually warrants further systematic evaluation in\nFigure 4. Alveolar echinococcosis in a 55-year-old man.(a) Axial unenhanced T1-weighted Magnetic Resonance (MR) image shows\ninﬁltrating diffused mass with hypo-intense signal in the right and left lobes of the liver. (b) Axial unenhanced T2-weighted MR image shows\nheterogeneous signal. The high signal intensity corresponds to small cystic and necrotic components of mass lesion. (c) Axial enhanced\nT1-weighted image with gadolinium shows no enhancement in the mass lesion. (d, e) Diffusion-weighted MR images obtained with b value\nof 0 s/mm\n2 and 600 s/mm2. Hypo-intense signal characterizes the cystic and necrotic components of the lesion whereas hyper-intense signal\nseen in the central necrotic part reveals restricted diffusion due to bacterial superinfection. (f) MR Cholangiopancreatography of the liver\nshows several small cystic and necrotic components of the mass lesion with dilated right hepatic duct, constricted upper part of common bile\nduct, and mildly dilated pancreatic duct.\nFigure 3. Alveolar echinococcosis in a patient with immunosuppression.(a) Abdominal gray-scale US shows an abscess-like hepatic image.\n(b) Axial unenhanced CT shows a typical aspect of pyogenic liver abscess.\n6 W . Liu et al.: Parasite 2014, 21,7 4\na higher number of AE patients with AE metastases in various\nlocations, at various stages, and in patients with and without\nimmunosuppression.\n4. Staging of HAE\nStaging of AE is the process of determining how much lar-\nval tissue there is in the body and where it is located. In addi-\ntion, staging has a prognostic objective, since it describes the\nextent and location of an individual’ s hepatic lesion based on\nits proximity to bile ducts and hepatic vessels, and the extent\nof its spread, locally and distantly in the body. Such a staging\nsystem was designed by the WHO-Informal Working Group on\nEchinococcosis, on the model of the ‘‘TNM’ ’ classiﬁcation and\nstaging of tumors, to be simply applicable in different settings\n(Table 1). It aims at facilitating communication among clini-\ncians, providing guidance for the most appropriate treatment\nstrategy, and gaining standardized information on the course\nand outcome of the disease. In addition, determining the stage\ncan also help to identify patients that could be recruited for\nmulticenter trials [24].\nThe stage of AE is based on three main factors: (1) Loca-\ntion and extension of the primary (original) parasitic lesion\nwithin the liver (P); (2) Involvement of neighboring organs\n(whether or not the larva has spread to the nearby tissues/\norgans, including lymph nodes) (N); (3) Presence or absence\nof metastasis (whether or not the larva has spread to distant\nareas of the body, such as the lungs, brain, bones, or any other\nlocation) (M).\nFigure 6. 18F-Fluorodeoxyglucose (FDG) Positron-emission tomography (PET) aspects of extrahepatic alveolar echinococcosis.(a) Brain\nmetastasis of alveolar echinococcosis. (b) Right atrium metastasis of alveolar echinococcosis.\nFigure 5. 18F-Fluorodeoxyglucose (FDG) Positron-emission tomography (PET) aspects of hepatic alveolar echinococcosis.(a) Early image\nacquisition (1 hour after FDG injection): large-sized heterogeneous space-occupying lesion in the right lobe of the liver, with multiple\nscattered calciﬁcations and areas of liquefaction necrosis, without obvious FDG uptake inside the lesion; signiﬁcant FDG uptake at the border\nof the lesion, at the junction of the right and left lobes, irregular in shape. (b) Delayed image acquisition (3 hours after FDG injection):\nsigniﬁcantly enhanced images of FDG uptake, with an increase in SUV value. (c) Pathology of the HAE lesion sampled in the area of high\nFDG uptake: ﬁbroblast proliferation, associated with macrophage, lymphocyte, plasma cell, and eosinophil-rich inﬂammatory inﬁltrate.\nW . Liu et al.: Parasite 2014, 21,7 4 7\nThe overall purpose of the PNM classiﬁcation is to\nimprove the quality of treatment and allow uniform evaluation\nof outcomes across healthcare institutions [ 24, 43]. Results\nobtained by the various imaging techniques are crucial to\ndetermine the PNM classiﬁcation for a given patient and in\neach institution should serve as a basis for the multidisciplinary\nevaluation of each case and common decision on the patient’ s\ncare management. This makes ultrasonographers, radiologists,\nand nuclear medicine specialists key actors for the care man-\nagement of patients with HAE.\n5. Innovation and advanced imaging for HAE\nMore advanced techniques complementary to conventional\nUS, CT, and MRI have been described in the last decade and\ncould be of help to improve diagnosis, indication for treatment,\nand/or follow-up of patients with HAE. However, until now,\nsuch techniques have been used in a limited number of AE\nreferral centers, most often in only one center. Their diagnostic\nusefulness, compared to other more conventional approaches,\nhas not been fully evaluated; and they cannot be recommended\nfor routine use until such an evaluation has been performed.\nThe following sections will thus be mostly descriptive, in antic-\nipation of further evidence for wider use of the various tech-\nniques currently under study.\n5.1. Innovation in US imaging of HAE\nMicro-bubble contrast agents have been developed to\nimprove US imaging and the technique of ‘‘contrast-enhanced\nultrasonography’’ (CEUS) has been proposed for the diagnosis\nand evaluation of AE lesions. However, the nature of the\nimages and the clinical interest of CEUS in AE were initially\ncontroversial. First attempts used contrast-enhanced wide-band\nDoppler ultrasonography, with Levovist\n/C210 as a contrast agent:\nIn ﬁve patients with AE, Suzuki et al. [ 41] observed defect\npatterns with distinct and irregular margins looking like\n‘‘worm-eaten defects’’, and proposed Levovist\n/C210 -CEUS as a\nclinically useful imaging method for the early diagnosis of\nAE and improvement in lesion size evaluation. However, using\nthe same technique [ 26], Kratzer et al. reported that even\nthough Levovist\n/C210 -CEUS could improve the demarcation of\nthe lesion from the surrounding tissue, it could not detect\nincreased vascularization in any of the 15 patients studied.\nA signiﬁcant improvement in CEUS has come with the use\nof SonoVue\n/C210 as the contrast agent. In 2007, the same German\nteam [17] compared hepatic lesions in patients with conﬁrmed\nAE using CEUS, three-phase helical CT and FDG-PET and\ndemonstrated that CEUS had higher concordance with\nFDG-PET in exploring the activity of AE than CT and was\neven more sensitive than FDG-PET/CT to identify ‘‘disease\nactivity’’. In their study, FDG-PET identiﬁed increased meta-\nbolic activity in the lesions in 7 patients (41.2%); a typical vas-\ncularization pattern of the lesions was visualized in nine\npatients (52.9%) by CEUS and in four patients (23.5%) by\nCT. All positive FDG-PET ﬁndings were also positive on\nCEUS. More recently [ 42], 17 Chinese patients with 19 AE\nlesions were examined with ‘ ‘basic US’’, color Doppler ﬂow\nimaging (CDFI), and then CEUS, before any treatment.\nExamined by basic US, 47.4% of AE lesions showed irregular\nhyperechoic areas and 52.6% appeared as having a mixed ech-\notype with irregular anechoic areas in the central part of the\nlesions. CDFI indicated no blood ﬂow signals inside any of\nthe 19 lesions. By CEUS, all 19 lesions displayed a circular\nrim enhancement in the peripheral areas and no enhancement\nwithin the central areas of the lesions (a ‘‘black hole’’ effect)\n(Fig. 7). As a result, the lesion margins were clear, irregular,\nand distinct. In general, the sizes of all AE lesions observed\nby CEUS were larger than those obtained by basic non-\ncontrast-enhanced US. The last two studies strongly suggested\nthat CEUS could bring about signiﬁcant improvement in\nthe follow-up of AE patients, by decreasing the number of\nFDG-PET/CT exams performed, thus reducing patient\nFigure 7. Contrast-enhanced Ultrasonography (CEUS) using SonoVue/C210 in a case of hepatic alveolar echinococcosis.CEUS showed a\nhepatic mass with irregular rim enhancement in the peripheral areas and no enhancement within the central areas at the hepatic artery phase\n(25 s).\n8 W . Liu et al.: Parasite 2014, 21,7 4\nirradiation and the cost of follow-up. However, in all series of\ncases under study, the number of patients included (5–17\npatients) as well as the variety of lesions, according to the usual\nimaging classiﬁcations of AE, were rather limited. Their\nresults should be extended to a larger number of patients before\nformally recommending CEUS as a standard imaging exam for\nthe follow-up of AE. In addition, the disappearance of\nthe ‘‘metabolic activity’’ of the lesions, as assessed by\nFDG-PET/CT, which is recommended to decide upon medical\ntreatment withdrawal, is likely different from the information\nabout lesion vascularization given by CEUS. Moreover, the\nuse of CEUS images as a basis for treatment withdrawal has\nnever been reported and correlation with speciﬁc antibody dis-\nappearance, another surrogate marker of parasite inactivity, has\nnever been studied.\nIn Xinjiang Medical University hospital, experimental\nstudies have complemented the ﬁrst clinical experience with\nCEUS, and they give some clues as to the pathological substra-\ntum of CEUS images. Such studies in E. multilocularis-\ninfected rats using CEUS have shown that the enhancement\nof early lesions can generally be divided into two different\ntypes [52]. Lesions of a size smaller than 3 mm exhibited ring\nenhancement during the arterial phase and no enhancement\nduring the portal-venous phase. The larger lesions showed ring\nand central septa enhancement during the arterial and portal-\nvenous phases. Pathologically, all these lesions were identiﬁed\nas single vesicle- or multiple vesicle-structures with a sur-\nrounding inﬂammatory reaction belt including proliferation\nof small vessels around the lesions. WithE. multilocularisfur-\nther growth, advanced lesions presented the typical ring\nenhancement at the arterial phase and no enhancement in the\ncenter of lesions at the arterial and portal-venous phases.\nMicroscopic examination of the pathological samples identi-\nﬁed all the lesions as multiple vesicle-structures mixed with\nﬁbrous tissue, surrounded by an inﬂammatory reaction belt,\nstill including proliferating small vessels around the lesions.\nBecause SonoVue\n/C210 is a blood pool contrast agent, it may be\nanticipated that the proliferation of small blood vessels in the\ninﬂammatory reaction belt is the basis for the enhancement\nafter injection of the contrast agent. The regular enhancement\npattern suggests that the main blood supply of those smaller\nlesions was mainly the hepatic artery. However, because of\nthe progression of obstruction and subsequent destruction of\nsmall arterial vessels, portal vein ﬂow could participate in\nblood supply of bigger lesions. All the experimental data thus\nsuggest that CEUS can demonstrate the real host-derived\nmicro-vessel perfusion in HAE [52].\n5.2. Innovation in CT imaging of HAE\nUnlike traditional CT imaging which can only reveal the\nmorphology and density of pathological lesions, Energy CT\n(including Dual Energy CT, DECT, and Spectral CT, SCT) is\na new approach for functional imaging which improves mate-\nrial differentiation [30]. Much research has been conducted on\nEnergy CT for the detection of small lesions, positive and dif-\nferential diagnosis of tumors, treatment efﬁcacy assessment,\nand prognosis evaluation [18].\nCT perfusion has been used to detect micro-circulation in\nHAE lesions, and showed that there was a different level of\nblood perfusion at the margins of HAE lesions, and a good cor-\nrelation between blood ﬂow, blood volume and micro-vessel\ndensity (MVD) in the same regions of HAE lesions [ 49]\n(Fig. 8). However, the high radiation dose of this technique\nlimits its integration into routine clinical practice. Energy CT\nmay more safely demonstrate the same changes in blood sup-\nply by measuring parameters of iodine quantiﬁcation (Kev\nvalue, attenuation curves, and iodine concentration) in selected\nareas of HAE lesions. A study performed at Xinjiang Medical\nUniversity Hospital in 24 patients showed an excellent correla-\ntion between iodine concentration measurements and MVD\n(r =0 . 9 4 0 ,p < 0.05) in the marginal zone of HAE lesions\nusing DECT ( Fig. 9 ). Iodine concentration in the marginal\nzone of a HAE lesion was signiﬁcantly higher than in\nthe solid and cystic components; iodine concentration mea-\nsurements were signiﬁcantly different between the marginal\nzone and the solid component of HAE lesions, both at the\nartery phase (1.63 mg/mL vs. 0.42 mg/mL, p = 0.001) and\nat the portal-venous phase (1.84 mg/mL vs. 0.62 mg/mL,\np = 0.001), while mean attenuation values were not signiﬁ-\ncantly different in both phases (55.4 HU vs. 47.2 HU,\np = 0.063 and 64.4 HU vs. 52.6 HU, p = 0.052, respectively).\nAnother study, using SCT, showed that the optimal monoener-\ngetic imaging for HAE was in the level of 65 Kev and different\ncomponents of HAE lesions could be mapped out by using the\ndifferent energy attenuation curve: the features of energy spec-\ntrum curves of ﬁve different patients were similar, although\ntheir solid component X-ray absorption values on CT were dif-\nferent. In addition, the fused iodine map clearly delineated the\nenhanced and well-perfused parts of the AE lesion marginal\nzone. Such observations probably reﬂect the neo-vasculariza-\ntion of the periparasitic inﬂammation developed at the border\nof the adjacent liver parenchyma. Comparison between results\nof spectral CT and PET -CT in 14 patients found that the\nenhanced and well-perfused region of AE in spectral CT was\nconsistent with PET -CT ﬁndings (Fig. 10).\nThese preliminary results indicate that spectral CT imaging\nbased on the spectral differentiation of iodine is technically\nfeasible and can quantitatively identify the micro-perfusion sta-\ntus of the periparasitic granulomatous reaction, and indirectly, as\nPET imaging does, albeit based on different pathological sub-\nstratum, reﬂect the activity of AE lesions. Although they are\nquite encouraging, these preliminary data should be completed\nby a prospective systematic study of the information provided by\nDECTand SCT to assess their cost and risk/beneﬁt value for the\nfunctional evaluation of HAE lesions and/or for the follow-up of\npatients with HAE, compared to the available imaging tools.\n5.3. Innovation in MRI imaging for HAE\nWith recent developments in gradient technology, multi-\nchannel coils, echo-planar sequences, and parallel imaging\ntechniques, MR-diffusion-weighted imaging (DWI) has\nbecome a promising technique for characterizing liver lesions.\nDWI exploits the microscopic random mobility of water pro-\ntons to measure the diffusion of ﬂuids in tissue [27 ]. Tissue\nW . Liu et al.: Parasite 2014, 21,7 4 9\nFigure 9. Alveolar echinococcosis in a 23-year-old woman.(a) Plain CT shows an inﬁltrative tumor-like mass with irregular margin and\nheterogeneous density in the right lobe of the liver. (b) Enhanced CT scan shows mild enhancement at the edge of the mass. (c) Iodine map of\nSpectral CT shows iodine distribution in the liver and lesion. (d) Micro-vessel density on histopathology of the iodine-enhanced area.\nFigure 8. Alveolar echinococcosis in a 34-year-old man.(a) CT plain scan shows a cyst-solid mixed hepatic mass involving both lobes of\nliver with irregular margin and necrosis areas of low density in the center. (b) Post-contrast phase shows a non-enhancing, hypo-attenuating\nlesion. (c) Blood ﬂow map, and (d) blood volume map, at CT perfusion, show the micro-circulation in the marginal area of AE.\n10 W . Liu et al.: Parasite 2014, 21,7 4\nregions with restricted water diffusion (e.g. malignant lesions)\nare displayed as regions of high signal intensity. Signal inten-\nsity on DWI can be quantiﬁed by calculating the apparent dif-\nfusion coefﬁcient (ADC), a valuable indicator for the diagnosis\nand characterization of focal hepatic lesions [14]. Typically, in\nHAE the lesions appear hypo-intense on DWI obtained with a\nb value of <500 s/mm\n2, which results in a higher ADC in the\nlesion than in the liver parenchyma [15, 38].\nFigure 10. Comparison between spectral CT, PET-CT and MR-DWI images.(a, b, c) The iodine map clearly delineates the well-perfused\nparts of hepatic alveolar echinococcosis in the marginal zone; (d, e) the enhanced and perfused region of AE in spectral CT was consistent\nwith PET -CT image that displayed high uptake, and (f ) MR-DWI that displayed high signal.\nFigure 11. Alveolar echinococcosis in a 45-year-old patient with hepatic alveolar echinococcosis (HAE).(a) T2-weighted MR images\nshowed a heterogeneous mass: note the multiple vesicles in the lesion, which showed a well-deﬁned border on enhanced T1WI due to the\nabsence of enhancement of the lesion itself (b). (c) Diffusion-weighted MR images revealed a half circular hyper-intensity area at the lesion’ s\nborder with the normal liver parenchyma, which was conﬁrmed to be metabolically active by PET (d) and PET/CT (e). (f ) HAE peripheral\narea was composed of severe ﬁbrosis combined with a large number of inﬂammatory cells on the histopathological sections (Masson\nstaining; ·100).\nW . Liu et al.: Parasite 2014, 21,7 4 11\nAt Xinjiang Medical University hospital, we performed\npreliminary studies on the utility of DWI in detection and char-\nacterization of HAE. Our initial study revealed that DWI might\nimprove both the detection and the characterization of HAE\nlesions. We found a clear advantage of DWI over conventional\nMR protocols in detecting 59 vs. 52 lesions in patients with\nHAE; DWI was especially better for detecting small lesions\nless than 1 cm. In 51 of 59 lesions, with DWI, we observed\na peri-lesional higher signal, which was displayed as a contin-\nuous or discontinuous circular ring of 2–3 mm thickness,\nmainly at the lesion’ s border with the ‘‘normal’’ liver paren-\nchyma [51]. Such a peri-lesional hyper-signal on DWI could\nbe detected in T2-weighted sequence in only 11 lesions; and\nit was displayed as only slightly hyper-intense. Because of such\nimpressive results, and as MRI-DW sequences can be easily\nand quickly performed in clinical practice, even without\nbreathing-control and intravenous contrast injection [ 14],\nDWI has already become a routine sequence for HAE\ndetection and evaluation in our center ( Figs. 4d and 4e).\nHowever, this approach cannot be widely recommended\nand to gain further diagnostic status, DWI should be prospec-\ntively evaluated in other populations of patients, especially in\nregions like Europe where less advanced HAE cases and\nHAE cases in immunosuppressed patients are routinely\ndiagnosed.\nWe have also analyzed the DWI features of the different\ncomponents of HAE lesions in 27 cases. Correlations between\nDWI ADC values and histological markers including micro-\nvessel density (MVD) and percentage of ﬁbrosis (quantiﬁed\non pathology sections using Masson staining) were studied.\nThere were signiﬁcant differences among ADC values in the\ndifferent areas of HAE lesions. Especially, there was a signif-\nicant inverse correlation between ADC values and percentage\nof ﬁbrosis in the peripheral area of HAE lesions (r = /C00.767,\np = 0.001). However, there was no signiﬁcant relationship\nbetween ADC values and MVD in the peripheral area\n(Fig. 11 ). According to these observations, it appears that\nADC values on DWI could represent a potential index of the\nﬁbrosis state, but have no value in assessing the peri-lesional\nmicro-circulation of HAE lesions [34, 51]. This ﬁts well with\nthe known physics mechanisms that underpin DWI.\nFinally, the potential value of the hyper-intensity zones dis-\nclosed using DWI as markers of disease activity was estimated\nin seven patients by comparing their location with PET/CT\nimages obtained at the same period of time. The location of\nthe peri-lesional hyper-intense areas in HAE lesions on DWI\nimaging was just similar to the location of the ‘‘positive’’\nimages in PET/CT imaging. Investigation of more cases is still\nunderway, and the relationship with Kodama types deﬁned on\nusual T1- and T2-weighted sequences would be worth check-\ning, since hyper-intensity on DWI might also be correlated\nto the presence of micro-cysts.\nReferences\n1. Azizi A, Blagosklonov O, Lounis A, Berthet L, Vuitton DA,\nBresson-Hadni S, Delabrousse E. 2014. Alveolar echinococcosis:\ncorrelation between hepatic MRI ﬁndings and FDG-PET/CT\nmetabolic activity. Abdominal Imaging, 39, Jun 27 [Epub ahead\nof print].\n2. Baron RW , Tanner CE. 1976. The effect of immunosuppression\non secondary Echinococcus multilocularis infections in mice.\nInternational Journal for Parasitology, 6, 37–42.\n3. Bartholomot G, Vuitton DA, Harraga S, Shi DZ, Giraudoux P ,\nBarnish G, Wang YH, MacPherson CN, Craig PS. 2002.\nCombined ultrasound and serologic screening for hepatic\nalveolar echinococcosis in central China. American Journal\nof Tropical Medicine and Hygiene, 66, 23–29.\n4. Bresson-Hadni S, Delabrousse E, Blagosklonov O,\nBartholomot B, Koch S, Miguet JP , Mantion GA, Vuitton\nDA. 2006. Imaging aspects and non-surgical interventional\ntreatment in human alveolar echinococcosis. Parasitology\nInternational, 55, S267–S272.\n5. Bresson-Hadni S, Grenouillet F , Knapp J, Demonmerot F ,\nRichou C, Vuitton DA, Millon L, the FrancEchino and\nEchinoVista networks. 2014. Reference-centre network for\nthe care management of alveolar echinococcosis: the Franc-\nEchino and EchinoVista experience, in Proceedings of the\ninternational symposium ‘‘Innovation for the management of\nechinococcosis’’, Besançon, March 27–29, 2014, Vuitton DA,\nMillon L, Gottstein B, Giraudoux P , Editors. Parasite, 21, 28,\n63–64.\n6. Bresson-Hadni S, Liance M, Meyer JP , Houin R, Bresson JL,\nVuitton DA. 1990. Cellular immunity in experimental Echino-\ncoccus multilocularisinfection. II. Sequential and comparative\nphenotypic study of the periparasitic mononuclear cells in\nresistant and sensitive mice. Clinical and Experimental Immu-\nnology, 82, 378–383.\n7. Bresson-Hadni S, Mantion GA, Vuitton DA. 2004. Alveolar\nechinococcosis in the Paris area. Gastroentérologie Clinique et\nBiologique, 28, 1147–1151.\n8. Brunetti E, Kern P , Vuitton DA, Writing Panel for the WHO-\nIWGE. 2010. Expert consensus for the diagnosis and treatment\nof cystic and alveolar echinococcosis in humans. Acta Tropica,\n114, 1–16.\n9. Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F ,\nRichou C, Boulahdour H, Blagosklonov O. 2013. The role of\ndelayed 18F-FDG PET imaging in the follow-up of patients\nwith alveolar echinococcosis. Journal of Nuclear Medicine, 54,\n358–363.\n10. Chauchet A, Grenouillet F , Knapp J, Richou C, Delabrousse E,\nDentan C, Millon L, Di Martino V , Contreras R, Deconinck E,\nBlagosklonov O, Vuitton DA, Bresson-Hadni S. 2014.\nIncreased incidence and characteristics of alveolar echinococ-\ncosis in patients with immunosuppression-associated condi-\ntions. Clinical Infectious Diseases, 59, 1095–1104.\n11. Cos/C223kun A, Oztürk M, Karahan OI, Erdogan N, Is/C223in S, Güleç M.\n2004. Alveolar Echinococcosis of the Liver: Correlative Color\nDoppler US, CT, and MRI Study. Acta Radiologica, 45, 492–498.\n12. Craig P . 2003. Echinococcus multilocularis. Current Opinion in\nInfectious Diseases, 16, 437–444.\n13. Crouzet J, Grenouillet F , Delabrousse E. 2010. Personalized\nmanagement of patients with inoperable alveolar echinococco-\nsis undergoing treatment with albendazole: usefulness of\npositron-emission-tomography combined with serological and\ncomputed tomography follow-up. Clinical Microbiology and\nInfection, 16, 788–791.\n14. Culverwell AD, Sheridan MB, Guthrie JA, Scarsbrook AF .\n2013. Diffusion-weighted MRI of the liver – Interpretative\npearls and pitfalls. Clinical Radiology, 68, 406–414.\n12 W . Liu et al.: Parasite 2014, 21,7 4\n15. Dohan A, Soyer P , Guerrache Y , Hoeffel C, Gavini JP , Kaci R,\nBoudiaf M. 2014. Focal nodular hyperplasia of the liver:\ndiffusion-weighted magnetic resonance imaging characteristics\nusing high B values. Journal of Computer Assisted\nTomography, 38, 96–104.\n16. Eckert J, Deplazes P . 2004. Biological, epidemiological, and\nclinical aspects of echinococcosis, a zoonosis of increasing\nconcern. Clinical Microbiology Reviews, 17, 107–135.\n17. Ehrhardt AR, Reuter S, Buck AK, Haenle MM, Mason RA,\nGabelmann A, Kern P , Kratzer W . 2007. Assessment of disease\nactivity in alveolar echinococcosis: a comparison of contrast-\nenhanced ultrasound, three-phase helical CT and 18F ﬂuoroxy-\nglucose positron-emission tomography. Abdominal Imaging,\n32, 730–736.\n18. Fornaro J, Leschka S, Hibbeln D. 2011. Dual- and multi-energy\nCT: approach to functional imaging. Insights in Imaging, 2,\n149–159.\n19. Gottstein B, Dai WJ, Walker M, Stettler M, Müller N, Hemphill A.\n2002. An intact laminated layer is important for the establishment\nof secondary Echinococcus multilocularisinfection. Parasitology\nResearch, 88, 822–828.\n20. Gottstein B, Haag K, Walker M, Matsumoto J, Mejri N,\nHemphill A. 2006. Molecular survival strategies of Echino-\ncoccus multilocularis in the murine host. Parasitology Interna-\ntional, 55, 45–49.\n21. Guerret S, Vuitton DA, Liance M, Pater C, Carbillet JP . 1998.\nEchinococcus multilocularis: relationship between susceptibil-\nity/resistance and liver ﬁbrogenesis in experimental mice.\nParasitology Research, 84, 657–667.\n22. Karçaaltincaba M, Sirlin CB. 2011. CT and MRI of diffuse\nlobar involvement pattern in liver pathology. Diagnostic and\nInterventional Radiology, 17, 334–342.\n23. Kern P , Bardonnet K, Renner E, Auer H, Pawlowski Z,\nAmmann RW , Vuitton DA, Kern P . 2003. European echinococ-\ncosis registry: human alveolar echinococcosis, Europe,\n1982–2000. Emerging Infectious Diseases, 9, 343–349.\n24. Kern P , Wen H, Sato N, Vuitton DA. 2006. WHO classiﬁcation\nof alveolar echinococcosis: principles and application. Parasi-\ntology International, 55, S283–S287.\n25. Kodama Y , Fujita N, Shimizu T. 2003. Alveolar echinococco-\nsis: MR ﬁndings in the liver. Radiology, 228, 172–177.\n26. Kratzer W , Reuter S, Hirschbuehl K, Ehrhardt AR, Mason RA,\nHaenle MM, Kern P , Gabelmann A. 2005. Comparison of\ncontrast-enhanced power Doppler ultrasound (Levovist) and\ncomputed tomography in alveolar echinococcosis. Abdominal\nImaging, 30, 286–290.\n27. Le Moigne F , Durieux M, Bancel B, Boublay N, Boussel L,\nDucerf C, Berthezène Y , Rode A. 2012. Impact of diffusion-\nweighted MR imaging on the characterization of small\nhepatocellular carcinoma in the cirrhotic liver. Magnetic\nResonance Imaging, 30, 656–665.\n28. Lin R Y , Wang JH, Lu XM, Zhou XT, Mantion G, Wen H,\nVuitton DA, Richert L. 2009. Components of the mitogen-\nactivated protein kinase cascade are activated in hepatic cells\nby Echinococcus multilocularismetacestode. World Journal of\nGastroenterology, 15, 2116–2124.\n29. Macpherson CN, Bartholomot B, Frider B. 2003. Application\nof ultrasound in diagnosis, treatment, epidemiology, public\nhealth and control of Echinococcus granulosus and E. multi-\nlocularis. Parasitology, 127, 21–35.\n30. Mileto A, Marin D, Nelson RC. 2014. Dual energy MDCT\nassessment of renal lesions: an overview. European Radiology,\n24, 353–362.\n31. Piarroux M, Piarroux R, Giorgi R, Knapp J, Bardonnet K,\nSudre B, Watelet J, Dumortier J, Gérard A, Beytout J, Abergel\nA, Mantion G, Vuitton DA, Bresson-Hadni S. 2011. Clinical\nfeatures and evolution of alveolar echinococcosis in France\nfrom 1982 to 2007: results of a survey in 387 patients. Journal\nof Hepatology, 55, 1025–1033.\n32. Polat KY , Ozturk G, Aydinli B, Kantarci M. 2004. Images of\ninterest. Hepatobiliary and pancreatic: alveolar hydatid disease.\nJournal of Gastroenterology and Hepatology, 19, 1319.\n33. Porot C, Knapp J, Wang J, Camporese D, Germain S, Seimbille\nY , Vuitton DA, Gottstein B, Blagosklonov O. 2014. Develop-\nment of a speciﬁc tracer for alveolar echinococcosis metabolic\nimaging: a preclinical study, in Proceedings of the IEEE\nEngineering in Medicine and Biology Society. Annual Meeting.\nIEEE: Chicago. p. 5587–5590, http://dx.doi.org/10.1109/\nEMBC.2014.6944893.\n34. Ren B, Wang J, Liu W . 2012. Comparative study between\ndiffusion weighted imaging and histopathological features in\nhepatic alveolar echinococcosis. Chinese Journal of Radiology,\n46, 57–61.\n35. Reuter S, Buck A, Manfras B, Kratzer W , Seitz HM, Darge K,\nReske SN, Kern P . 2004. Structured treatment interruption in\npatients with alveolar echinococcosis. Hepatology, 39, 509–517.\n36. Reuter S, Grüner B, Buck AK, Blumstein N, Kern P , Reske SN.\n2008. Long-term follow-up of metabolic activity in human alveolar\nechinococcosis using FDG-PET. Nuklearmedizin, 47, 147–152.\n37. Reuter S, Schirrmeister H, Kratzer W . 1999. Pericystic\nmetabolic\nactivity in alveolar echinococcosis: assessment and\nfollow-up by positron emission tomography. Clinical Infectious\nDiseases, 29, 1157–1163.\n38. Sandrasegaran K, Tahir B, Nutakki K, Akisik FM, Bodanapally U,\nTann M, Chalasani N. 2013. Usefulness of conventional MRI\nsequences and diffusion-weighted imaging in differentiating\nmalignant from benign portal vein thrombus in cirrhotic patients.\nAmerican Journal of Roentgenology, 201, 1211–1219.\n39. Scharf G, Deplazes P , Kaser-Hotz B. 2004. Radiographic,\nultrasonographic, and computed tomographic appearance of\nalveolar echinococcosis in dogs. Veterinary Radiology and\nUltrasound, 45, 411–418.\n40. Stumpe KD, Renner-Schneiter EC, Kuenzle AK. 2007. F-18-\nﬂuorodeoxyglucose (FDG) positron-emission tomography of\nEchinococcus multilocularis liver lesions: prospective evalua-\ntion of its value for diagnosis and follow-up during benzimid-\nazole therapy. Infection, 35, 11–18.\n41. Suzuki Y , Fujimoto Y , Hosoki Y , Suzuki M, Inoue M, Sakurai S,\nOhtake T, Ohhira M, Saito H, Kohgo Y . 2003. Usefulness of\ncontrast-enhanced wide-band Doppler ultrasonography to diag-\nnose alveolar echinococcosis of the liver and evaluate the effect of\nthe treatment. European Journal of Radiology, 48, 305–311.\n42. Tao S, Qin Z, Hao W , Y ongquan L, Lanhui Y , Lei Y . 2011.\nUsefulness of gray-scale contrast-enhanced ultrasonography in\ndiagnosing hepatic alveolar echinococcosis. Ultrasound in\nMedicine and Biology, 37, 1024–1028.\n43. Türkbey B, Aras O, Karabulut N. 2012. Diffusion-weighted\nMRI for detecting and monitoring cancer: a review of current\napplications in body imaging. Diagnostic and Interventional\nRadiology, 18, 46–59.\nW . Liu et al.: Parasite 2014, 21,7 4 13\n44. Vuitton DA, Bresson-Hadni S. 2014. Alveolar echinococcosis:\nevaluation of the therapeutic strategies. Expert Opinion on\nOrphan Drugs, 2, 67–86.\n45. Vuitton DA, Bresson-Hadni S, Laroche L. 1989. Cellular\nimmune response in Echinococcus multilocularis infection in\nhumans. II. Natural killer cell activity and cell subpopulations\nin the blood and in the periparasitic granuloma of patients with\nalveolar echinococcosis. Clinical and Experimental Immunol-\nogy, 78, 67–74.\n46. Vuitton DA, Guerret-Stocker S, Carbillet JP , Mantion G,\nMiguet JP , Grimaud JA. 1986. Collagen immunotyping of the\nhepatic ﬁbrosis in human alveolar echinococcosis. Zeitschrift\nfür Parasitenkunde, 72, 97–104.\n47. Vuitton DA, Zhou H, Bresson-Hadni S. 2003. Epidemiology of\nalveolar echinococcosis with particular reference to China and\nEurope. Parasitology, 127, S87–S107.\n48. Wang J, Lin R, Zhang W , Li L, Gottstein B, Blagosklonov O,\nLü G, Zhang C, Lu X, Vuitton DA, Wen H. 2014. Transcrip-\ntional proﬁles of cytokine/chemokine factors of immune cell-\nhoming to the parasitic lesions: a comprehensive one-year\ncourse study in the liver of E. multilocularis-infected mice.\nPLoS One, 17, e91638.\n49. Wang J, Ren B, Liu W . 2011. Correspondence Analysis\nbetween perfusion CT and microvessel density, vascular endo-\nthelial growth factor in hepatic alveolar echinococcus. Chinese\nJournal of Radiology, 45, 1036–1039.\n50. Weiner SM, Krenn V , Koelbel C, Hoffmann HG, Hinkeldey K,\nOckert D. 2011. Echinococcus multilocularis infection and\nTNF inhibitor treatment in a patient with rheumatoid arthritis.\nRheumatology International, 31, 1399–1400.\n51. Xie W , Wang J, Liu W . 2012. The correlation between ADC and\nthe area of ﬁbrosis in border of hepatic alveolar echinococcosis.\nJournal of Practical Diagnosis and Therapy, 26, 467–470.\n52. Zeng H, Wang J, Xie W , Liu W , Wen H. 2012. Assessment of\nearly hepatic Echinococcus multilocularisinfection in rats with\nreal-time contrast-enhanced ultrasonography. Ultrasound in\nMedicine and Biology, 38, 1982–1988.\n53. Zhang C, Wang J, Lü G, Li J, Lu X, Mantion G, Vuitton DA,\nWen H, Lin R. 2012. Hepatocyte proliferation/growth arrest\nbalance in the liver of mice during E. multilocularisinfection: a\ncoordinated 3-stage course. PLoS One, 7, e30127.\nCite this article as:Liu W , Delabrousse É, Blagosklonov O, Wang J, Zeng H, Jiang Y , Wang J, Qin Y , Vuitton DA & Wen H: Innovation in\nhepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Parasite, 2014, 21, 74.\nAn international open-access, peer-reviewed, online journal publishing high quality papers\non all aspects of human and animal parasitology\nReviews, articles and short notes may be submitted. Fields include, but are not limited to: general, medical and veterinary parasitology;\nmorphology, including ultrastructure; parasite systematics, including entomology, acarology, helminthology and protistology, and molecular\nanalyses; molecular biology and biochemistry; immunology of parasitic diseases; host-parasite relationships; ecology and life history of\nparasites; epidemiology; therapeutics; new diagnostic tools.\nAll papers in Parasite are published in English. Manuscripts should have a broad interest and must not have been published or submitted\nelsewhere. No limit is imposed on the length of manuscripts.\nParasite (open-access) continues Parasite (print and online editions, 1994-2012) andAnnales de Parasitologie Humaine et Compare´e\n(1923-1993) and is the official journal of the Socie´te´ Franc ¸aise de Parasitologie.\nEditor-in-Chief: Submit your manuscript at\nJean-Lou Justine, Paris http://parasite.edmgr.com/\n14 W . Liu et al.: Parasite 2014, 21,7 4",
  "topic": "Echinococcus multilocularis",
  "concepts": [
    {
      "name": "Echinococcus multilocularis",
      "score": 0.8156996965408325
    },
    {
      "name": "Context (archaeology)",
      "score": 0.7052682638168335
    },
    {
      "name": "Radiology",
      "score": 0.6485752463340759
    },
    {
      "name": "Echinococcosis",
      "score": 0.6414583325386047
    },
    {
      "name": "Positron emission tomography",
      "score": 0.633089542388916
    },
    {
      "name": "Magnetic resonance imaging",
      "score": 0.5785009860992432
    },
    {
      "name": "Medicine",
      "score": 0.5145403742790222
    },
    {
      "name": "Stage (stratigraphy)",
      "score": 0.42397499084472656
    },
    {
      "name": "Pathology",
      "score": 0.22876504063606262
    },
    {
      "name": "Biology",
      "score": 0.14578095078468323
    },
    {
      "name": "Paleontology",
      "score": 0.0
    }
  ],
  "institutions": [
    {
      "id": "https://openalex.org/I2802734952",
      "name": "First Affiliated Hospital of Xinjiang Medical University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I154093214",
      "name": "Xinjiang Medical University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4210087978",
      "name": "Centre Hospitalier Universitaire de Besançon",
      "country": "FR"
    },
    {
      "id": "https://openalex.org/I90843659",
      "name": "Université de franche-comté",
      "country": "FR"
    }
  ]
}